A tough technical picture for Microsoft $MSFT. This is the first 200-Day SMA test since March 2023.
Disclaimer
This marketing document has been issued by Bank Syz Ltd. It is not intended for distribution to, publication, provision or use by individuals or legal entities that are citizens of or reside in a state, country or jurisdiction in which applicable laws and regulations prohibit its distribution, publication, provision or use. It is not directed to any person or entity to whom it would be illegal to send such marketing material. This document is intended for informational purposes only and should not be construed as an offer, solicitation or recommendation for the subscription, purchase, sale or safekeeping of any security or financial instrument or for the engagement in any other transaction, as the provision of any investment advice or service, or as a contractual document. Nothing in this document constitutes an investment, legal, tax or accounting advice or a representation that any investment or strategy is suitable or appropriate for an investor's particular and individual circumstances, nor does it constitute a personalized investment advice for any investor. This document reflects the information, opinions and comments of Bank Syz Ltd. as of the date of its publication, which are subject to change without notice. The opinions and comments of the authors in this document reflect their current views and may not coincide with those of other Syz Group entities or third parties, which may have reached different conclusions. The market valuations, terms and calculations contained herein are estimates only. The information provided comes from sources deemed reliable, but Bank Syz Ltd. does not guarantee its completeness, accuracy, reliability and actuality. Past performance gives no indication of nor guarantees current or future results. Bank Syz Ltd. accepts no liability for any loss arising from the use of this document.
Related Articles
Novo Nordisk (NVO) has seen its long-term bullish trend broken, with the stock losing 49% since its highs. It’s now trying to find support. On Friday, the stock rebounded from the major support zone between 504-535. The stock will likely be volatile in the coming days, so keep an eye on this support zone to see if it has found a low. Source: Bloomberg
Idexx Laboratories (IDXX US) recently tested the swing support zone between 372-431 and is now rebounding off that level with increasing volume. Source: Bloomberg
After a 47% consolidation over 2 years, Roche (ROG SW) broke its downtrend in June and has seen a 35% rally since the lows, suggesting that the low is now in place. The market is now back in the demand zone between 238-251, and we’re observing strong price action. The next key resistance to watch is 293.55. Source: Bloomberg